Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation by Waldemar E. Wysokinski, MD, PhD, Rowlens M. Melduni, MD, MPH, Naser M. Ammash, MD, Danielle T. Vlazny, PA-C, MS, Ewa Konik, MD, Rayya A. Saadiq, DO, Izabela Gosk-Bierska, MD, Joshua Slusser, BS, Diane Grill, MS, Robert D. McBane, MD

Get full text